Interesting that there is no commentary on progress with respect to the "29 employee head count reduction targeted for H1 FY2016", as commented in the last annual report.
Also, trading EBITDA guidance in FY2015 annual report was "in range $20m to $30m". In the AGM presentation this became "at the lower end" of previous guidance. In the latest (above) announcement it is "circa $20m".
I also love the way the company classes "profits" on asset sales as "trading EBITDA", but excludes write-downs. Very convenient.
Ann: Replacement Trading Update - 21/12/15, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.80M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.3¢ | 14.0¢ | $22.78K | 162.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101179 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 278210 | 4 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| BOL (ASX) Chart |
Day chart unavailable
